Park Place Capital’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-149
Closed -$5.46K 1091
2026
Q1
$5.46K Hold
149
﹤0.01% 672
2025
Q4
$6.8K Hold
149
﹤0.01% 622
2025
Q3
$6.31K Hold
149
﹤0.01% 617
2025
Q2
$4.58K Hold
149
﹤0.01% 671
2025
Q1
$3.66K Hold
149
﹤0.01% 687
2024
Q4
$4.26K Hold
149
﹤0.01% 676
2024
Q3
$3.97K Hold
149
﹤0.01% 714
2024
Q2
$3.82K Hold
149
﹤0.01% 727
2024
Q1
$3.15K Hold
149
﹤0.01% 780
2023
Q4
$2.66K Hold
149
﹤0.01% 777
2023
Q3
$2.26K Hold
149
﹤0.01% 914
2023
Q2
$2.56K Hold
149
﹤0.01% 927
2023
Q1
$1.95K Hold
149
﹤0.01% 948
2022
Q4
$2K Buy
+149
New +$1.79K ﹤0.01% 931

Other funds holding AORT

Park Place Capital's AORT Position: Q2 2026 in Review

Park Place Capital sold out of Artivion (AORT) in Q2 2026, closing a stake of 149 shares — an estimated $5.46K sold.

Park Place Capital first reported a position in AORT in Q4 2022 and held it in 14 quarters. The position peaked at $6.8K in Q4 2025. 207 funds tracked by Wall St. Rank hold AORT as of Q2 2026.

  • Park Place Capital reported no remaining Artivion position as of Q2 2026 after selling out during the quarter.
  • Park Place Capital sold 149 Artivion shares in Q2 2026, an estimated $5.46K.
  • Park Place Capital first reported a position in Artivion in Q4 2022 and held it in 14 quarters.
  • Park Place Capital's Artivion position peaked at $6.8K in Q4 2025.
  • 207 funds tracked by Wall St. Rank held Artivion as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.